Your introduction to drug safety (pharmacovigilance)
A DSRU and Royal Pharmaceutical Society collaborative event
Venue: Royal Pharmaceutical Society, 66-68 East Smithfield, London E1W 1AW
Date: Monday 18 Nov 2019
This collaborative event with the Royal Pharmaceutical Society is designed to explore why pharmacovigilance is important, how adverse drug reactions are reported and the role of a pharmacist in drug safety. The course will benefit staff interested in working in pharmacovigilance departments and will be of interest to a broad range of staff in pharmacy, the pharmaceutical industry, regulatory authorities and academia.
Monitoring drug safety is very important to public health. Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problems. In order to work in pharmacovigilance, it is essential to have a good working knowledge of the principles of drug safety, its regulations and proactive strategies for risk management and risk minimisation.
*Please note that the course dates and programme may be subject to change.
Who should attend?
Those with little or no knowledge of drug safety (pharmacovigilance), who wish to gain an understanding of the background and the methods used to reduce risks to patients.
Aims of course
- To provide you with a historical perspective of pharmacovigilance
- To ensure an understanding of basic terminology and provide definitions of key concepts
- To explain the role of pharmacists in drug safety
- To provide an overview of how adverse drug reactions are reported
- To introduce delegates to current key regulatory requirements
- To explain the methods in place to minimise the risks associated with drugs
On successful completion of this course delegates should be able to:
- Explain key drug safety definitions
- Demonstrate a good understanding of pharmacovigilance regulations
- Explain the process for reporting suspected adverse drug reactions
- Explain some of the methods that are in place to minimise the risks to patients
- What is pharmacovigilance?
- Pharmacovigilance for pharmacists
- Regulatory aspects of pharmacovigilance
- Reporting adverse drug reactions
- Methods of risk minimisation
Course Leader blog
“We are delighted to be joining forces with the Royal Pharmaceutical Society to provide this course to introduce pharmacovigilance to pharmacists. Pharmacovigilance is defined by the European Medicines Agency as “the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem.”
Monitoring safety and pharmacovigilance are key activities during the lifecycle of a medicine, both at the pre-marketing stage and once it is licensed for use in humans. No medicine is without risk of adverse effects and the science of drug safety involves assessing and optimising the risk-benefit balance for each medicine.
This course will detail the key role that pharmacists have to play in pharmacovigilance and will explain why it is important to report adverse drug reactions and methods for doing so. Presentations will be complemented by interactive sessions.
Routine risk minimisation measures are required for each drug and include the SmPC, PIL, packet size and the legal state. For products where these are considered insufficient, additional risk minimisation measures will be required in order to optimise the risk/benefit balance and maintain patient safety in everyday use of the drug. Community pharmacists are frequently involved in additional risk minimisation measures usually at the point at which a medicine is dispensed. For example, pharmacists may be asked to keep a log to indicate whether they have provided a patient card to the patient with their medicine (in addition to the PIL) and explained its use. The patient card may list serious potential side effects and actions to be taken in the event of occurrence.
This blog aims to provide you with a glimpse of the course. We do hope that you will be able to join us!”
Professor Saad Shakir MB ChB LRCP&S FRCP FFPM MRCGP, Director, DSRU and Course Leader
RPS Member: £195.00
Non-GphC Registrant: £395.00
Registration fees include:
- Access to all sessions;
- Delegate pack on arrival;
- Printed and electronic event resources;
- Refreshments and lunch;
- Certificate of attendance.
Download Course Programme
Click here to download the programme
“The courses gave me a really good insight into what pharmacovigilance is about. Not only from the conference speakers and course lecturers, but from the other participants who are from all across the industry and have different perspectives on things and different approaches”
“Excellent content and presentations. Very well put together. Enjoyed the practical aspects with workshops”
“Very informative and comprehensive course with good interactive sessions. Good, qualified speakers covered relevant topics in detailed manner.”